UTMD - Utah Medical Products Inc. Long-Term Debt Volume

Graphic logo of Utah Med (UTMD)

Utah Medical Products (UTMD) efficiency is based on the profitability of unique patented solutions and strict compliance with FDA standards. High assembly precision is ensured by robotic complexes equipped with machine vision systems. This price chart demonstrates the asset's dynamics, where the debt load is 0.00. Utah Medical Products (UTMD) relies on deep vertical integration, purchasing only basic polymers and keeping complex technical processes within its structure.

UTMD Utah Medical Products Company Long-Term Debts (07/04/2022 - 10/31/2026)

Utah Medical - analytical breakdowns and key metrics (UTMD)

- share price and expert price forecast:
Share Price utahmed.com|UTMD - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Utah Medical Products|UTMD - Enterprise Value
- balance sheet equity data:
Accounting Value per Share Utah Medical Products|UTMD - Book Capitalization|Market Capitalization to Book Value Ratio utahmed.com|UTMD - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Utah Medical Products|UTMD - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Utah Med|UTMD - Company Aggregate Debts|Debts to Net Assets Utah Medical Products|UTMD - Company Long-Term Debt|Company Short-Term Indebtedness Utah Medical Products|Interim Coverage Ratio utahmed.com
- earnings and multiples data:
UTMD - Net Income
Summary company analytics:UTMD utahmed.com
Manufactured products of Utah Med

Long-term debt defines the volume of obligations with a maturity exceeding twelve months, signaling the degree of financial pressure on capital. By analyzing long-term borrowings, the firm tracks credit load dynamics and the risk of balance sheet degradation prior to the publication of reports. An increase in this metric often indicates borrowing to scale operations. For Utah Medical Products (UTMD), such investments are typically directed toward the development of microengineering and R&D in neonatology.

Competitors of Utah Medical Products (UTMD)

ISRG: Company Long-Term Indebtedness|Danaher - Company Long-Term Debts|Long-Term Debt Volume BD BDX|STE: Company Long-Term Debts|Company Long-Term Liabilities West Pharma Corp|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts masimo.com|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt TFX (Teleflex Inc.)|Merit Medical Systems Inc - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings NVST|ICU Medical, Inc. - Company Long-Term Debts|Long-Term Debt Volume dentsplysirona.com XRAY|LeMaitre Vascular (LMAT) - Company Long-Term Debt|Company Long-Term Indebtedness ATRC|Company Long-Term Debt STAAR Surgical Corp|niagenbioscience.com (NAGE) - Long-Term Debt Volume|Company Long-Term Liabilities ZIMV (ZimVie Inc.)|Amount of Long-Term Liabilities ANGO|Company Long-Term Debt Cerus CERS|Company Long-Term Loans and Borrowings TKNO|MGRM: Company Long-Term Liabilities|STSS - Company Long-Term Debts|infusystem.com (INFU) - Company Long-Term Debt|Company Long-Term Liabilities KORU Medical|NYXH (Nyxoah) - Company Long-Term Debts|Long-Term Debt Microbot Medical, Inc. MBOT|Company Long-Term Debt Pro-Dex Corp (PDEX)|Zentek Corp - Company Long-Term Indebtedness|Elutia Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities MLSS (milestonescientific.com)|NXGL - Company Long-Term Debt|Long-Term Debt Volume Retractable Technologies RVP|HBIO (Harvard Bioscience, Inc.) - Company Long-Term Liabilities|Femasys Corporation (FEMY) - Company Long-Term Debts|Company Long-Term Liabilities MHUA|POAI (Predictive Oncology Corp) - Amount of Long-Term Liabilities|Company Long-Term Debts CJMB|Company Long-Term Debts Atrion Corp. (ATRI)|Company Long-Term Debts NURO (NeuroMetrix Corp)